跳至主要内容
临床试验/DRKS00031932
DRKS00031932尚未招募不适用

Evaluation of upper gastrointestinal tract surveillance in individuals with Lynch syndrome - EARLY study

ationales Zentrum für erbliche Tumorerkrankungen, Universitätsklinikum Bonn0 个研究点目标入组 5,000 人开始时间: 2024年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
5,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Signed informed consent
  • - Patient must be able to follow study instructions and expected to attend and complete all required study visits.
  • -Confirmed diagnosis of a (likely-) pathogenic germline variant in MLH1, MHS2, MSH6, PMS2 or EPCAM (Lynch Syndrome)

排除标准

  • -Subjects without legal capacity who are unable to understand the nature, scope, significance and consequences of this clinical trial
  • - Patients with a physical or mental condition that, in the judgment of the investigator, could pose a risk to the patient, confound the study results, or interfere with participation in the clinical study
  • - Personal history of duodenal or gastric surgery

研究者

发起方
ationales Zentrum für erbliche Tumorerkrankungen, Universitätsklinikum Bonn

相似试验

Evaluation of upper gastrointestinal tract... | 临床试验